Abstract

Objectives: The present study explores the potential of known peptide deformylase (PDF) inhibitors as chemotherapeutic agents against experimental tuberculosis. Methods: Several PDF inhibitors like BB-3497, actinonin, 1, 10-phenanthroline, hydroxylamine hydrochloride, and galardin that have shown their potential against other bacteria were selected for their evaluation against Mycobacterium tuberculosis. Results: Based on in vitro studies, the minimum inhibitory concentration (MIC) of PDF inhibitors was found to be in the range of 0.2 74mg/L, and among different PDF inhibitors, BB-3497 and 1, 10-phenanthroline exhibited potent antimycobacterial activity. In addition PDF inhibitors exhibited bacteriostatic mode of inhibition. Ex vivo studies with BB-3497 and actinonin led to reduction of colony forming units (cfu) by almost 2 log10 units at their MIC concentration. Moreover, reduction of cfu by BB3497 was comparable to that of isoniazid. Under short course chemotherapy, BB-3497 was significantly active and comparable to isoniazid. Extended chemotherapy of 6 weeks with BB-3497 and actinonin revealed BB-3497 to be more potent under in vivo condition. Interestingly, BB-3497 and actinonin exhibited synergism with isoniazid and rifampicin under in vitro conditions and during chemotherapy of murine tuberculosis. Conclusions: Peptide deformylase inhibitors like BB-3497 and actinonin showed their efficacy against Mycobacterium tuberculosis under in vitro, ex vivo and in vivo conditions and BB-3497 was found to be the most efficacious inhibitor. Thus PDF from M. tuberculosis appears to be an attractive target for development of new antibiotics against tuberculosis.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call